USPTO serial 79407494
MAXORPTION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 30, 2025
- Examiner
- COHEN, ROBERT ANDREW
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MAXORPTION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael F. Swartz
Michael F. Swartz Egbert, McDaniel & Swartz, PLLC1001 Texas Ave., Suite 1250Houston, TX 77002United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations containing omega 3 for treatment of cardiovascular diseases, cognitive decline, and inflammatory disorders; dietetic foods for medical use containing oils rich in EPA and DHA for treating dyslipidemia, metabolic syndrome, and neurodevelopmental disorders; nutritional supplements for human consumption for medical use containing oils rich in EPA and DHA that are of marine or microalgae origin for treating cardiovascular and metabolic disorders namely hypertriglyceridemia, metabolic syndrome, and type 2 diabetes, neurological and cognitive decline namely Alzheimer's disease and mild cognitive impairment, mood and psychiatric disorders namely depression and anxiety, inflammatory and autoimmune conditions namely rheumatoid arthritis and inflammatory bowel disease, and ophthalmic disorders namely dry eye syndrome and age-related macular degeneration; ophthalmic preparations containing omega-3; food supplements for medical use containing oils rich in EPA and DHA that are of marine or microalgae origin for treating cardiovascular diseases namely hypertriglyceridemia and atherosclerosis, neurodegenerative disorders namely Alzheimer's disease and cognitive decline, psychiatric conditions namely depression and anxiety, inflammatory and autoimmune diseases namely rheumatoid arthritis, and for supporting maternal and infant health namely healthy pregnancy, reduction of risk of preterm birth, optimal fetal brain and retinal development, and post-partum mental health; food supplements for specialized nutrition, infant nutrition; Nutraceuticals containing oils rich in EPA and DHA, targeting the microbiota for treating inflammatory bowel disease, irritable bowel syndrome and metabolic inflammation and intestinal dysbiosis; Nutritional dietetic food additives for medical, paramedical or pharmaceutical use in the nature of natural food extracts derived from fish; food supplements containing omega-3; food supplements derived from microalgae or marine oils | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 8, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 7, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 9, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 30, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 23, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 23, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 30, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 30, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 14, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 16, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 17, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 17, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 9, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 7, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 25, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 24, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |